These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2519873)
1. In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase. Quemener V; Quash G; Moulinoux JP; Penlap V; Ripoll H; Havouis R; Doutheau A; Goré J In Vivo; 1989; 3(5):325-30. PubMed ID: 2519873 [TBL] [Abstract][Full Text] [Related]
2. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Sladek NE; Landkamer GJ Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149 [TBL] [Abstract][Full Text] [Related]
4. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL; Wu MS; Chen Z Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia. Li LH; Wallace TL; Richard KA; Tracey DE Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice. Cantrell JE; Green D; Schein PS Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728 [TBL] [Abstract][Full Text] [Related]
7. [Growth-inhibitory activity of minocycline on various tumor cell lines in vitro]. Inaba M; Nagashima K Gan To Kagaku Ryoho; 1986 Jul; 13(7):2337-41. PubMed ID: 3729489 [TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26. Chiuten DF; Muggia FM; Johnson RK Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512 [No Abstract] [Full Text] [Related]
10. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Hilton J Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175 [TBL] [Abstract][Full Text] [Related]
11. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A. Rose WC; Schurig JE; Huftalen JB; Bradner WT Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399 [No Abstract] [Full Text] [Related]
12. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Burres NS; Clement JJ Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652 [TBL] [Abstract][Full Text] [Related]
13. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372 [TBL] [Abstract][Full Text] [Related]
15. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity. Lin TS; Fischer PH; Marsh JC; Prusoff WH Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884 [TBL] [Abstract][Full Text] [Related]
17. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives. Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935 [TBL] [Abstract][Full Text] [Related]
18. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars. Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170 [TBL] [Abstract][Full Text] [Related]
20. Alkylphosphonium salts as a new class of antitumor agents. Sanyal U; Chatterjee RS; Das SK; Chakraborti SK Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]